Germany In Vitro Fertilization Market Size & Outlook
The in vitro fertilization market in Germany is expected to reach a projected revenue of US$ 2,608.0 million by 2033. A compound annual growth rate of 5.12% is expected of Germany in vitro fertilization market from 2026 to 2033.
Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility
Other key industry trends
In terms of revenue, Germany accounted for 6.0% of the global in vitro fertilization market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Europe, Germany in vitro fertilization market is projected to lead the regional market in terms of revenue in 2033.
Germany is the fastest growing regional market in Europe and is projected to reach USD 2,608.0 million by 2033.
Medical tourism is growing in Germany owing to the presence of liberal laws pertaining to ART in the country. There has been a growing demand for IVF treatments in Germany, driven by factors such as delayed parenthood, changing social norms, and increasing awareness & acceptance of ARTs.
Furthermore, Germany is renowned for its advancements in medical technology and research. Technological innovations in IVF procedures, such as improved embryo selection techniques, genetic testing, & cryopreservation methods, have increased the success rates of IVF treatments and expanded the options available to patients.
Market players are making strategic new launches to leverage the growing demand, as well as to gain a stronger market position. In April 2022, Apryl, a Berlin-based company, successfully raised USD 4.85 million in a funding round led by Breega.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to In Vitro Fertilization Market Outlook will help companies and investors design strategic landscapes.
Frozen Nondonor was the largest segment with a revenue share of 51.75% in 2025.
Horizon Databook has segmented the Germany in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2021 to 2033.
Medical tourism is growing in Germany owing to the presence of liberal laws pertaining to ART in the country. There has been a growing demand for IVF treatments in Germany, driven by factors such as delayed parenthood, changing social norms, and increasing awareness & acceptance of ARTs.
Furthermore, Germany is renowned for its advancements in medical technology and research. Technological innovations in IVF procedures, such as improved embryo selection techniques, genetic testing, & cryopreservation methods, have increased the success rates of IVF treatments and expanded the options available to patients.
Market players are making strategic new launches to leverage the growing demand, as well as to gain a stronger market position. In April 2022, Apryl, a Berlin-based company, successfully raised USD 4.85 million in a funding round led by Breega.
Germany In Vitro Fertilization Market Procedure Type Outlook (Revenue, USD Million , 2021-2033)
Fresh Nondonor
Frozen Nondonor
Fresh Donor
Frozen Donor
Germany In Vitro Fertilization Market Providers Outlook (Revenue, USD Million , 2021-2033)
Fertility Clinics
Hospitals and Other Settings
Reasons to subscribe to In Vitro Fertilization Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of In Vitro Fertilization Market Outlook databook
Our clientele includes a mix of In Vitro Fertilization Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany In Vitro Fertilization Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Germany In Vitro Fertilization Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Germany In Vitro Fertilization Market, 2021-2033 (US$M)